{"result": "(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association (ADA) is a professional organization that provides guidelines and recommendations for the prevention and management of diabetes, including criteria for diagnosing diabetes and prediabetes.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 2<|>EVENT<|>Diabetes Mellitus Type 2 (DM2) is a chronic condition characterized by insulin resistance and high blood sugar levels, often associated with obesity and other risk factors.)\n##\n(\"entity\"<|>GLUCEMIA PLASMÁTICA<|>EVENT<|>Glucemia plasmática refers to the measurement of glucose levels in the blood, which is crucial for diagnosing diabetes and prediabetes.)\n##\n(\"entity\"<|>PREDIABETES<|>EVENT<|>Prediabetes is a condition where blood sugar levels are higher than normal but not high enough to be classified as diabetes, indicating an increased risk for developing DM2.)\n##\n(\"entity\"<|>HBA1C<|>EVENT<|>HbA1c is a blood test that measures average blood sugar levels over the past 2 to 3 months, used in the diagnosis and management of diabetes.)\n##\n(\"entity\"<|>IMC<|>EVENT<|>IMC, or Índice de Masa Corporal (Body Mass Index), is a measure used to classify individuals based on their weight relative to their height, often used to assess obesity risk for diabetes.)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>DIABETES MELLITUS TYPE 2<|>The American Diabetes Association provides guidelines and recommendations for the diagnosis and management of Diabetes Mellitus Type 2.<|>8)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>PREDIABETES<|>The American Diabetes Association outlines criteria for diagnosing prediabetes, which is a precursor to Diabetes Mellitus Type 2.<|>8)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 2<|>HBA1C<|>HbA1c levels are used to diagnose and monitor Diabetes Mellitus Type 2.<|>9)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 2<|>IMC<|>A high IMC is recognized as a risk factor for developing Diabetes Mellitus Type 2.<|>7)\n##\n(\"relationship\"<|>PREDIABETES<|>HBA1C<|>HbA1c levels are used to identify individuals with prediabetes, indicating a risk for developing Diabetes Mellitus Type 2.<|>8)\n##\n(\"relationship\"<|>PREDIABETES<|>IMC<|>A high IMC is a risk factor for prediabetes, which can lead to Diabetes Mellitus Type 2.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Señale la afirmación falsa respecto a los criterios de riesgo mayores para DM2:\n\nA. Sobrepeso con IMC ≥ 25 kg/m².\nB. Mujer con historia personal de diabetes gestacional.\nC. Mujer con síndrome de ovario poliquístico.\nD. HbA1c > 5,2%.\n\nCOMENTARIO\n\nEn las recomendaciones de la American Diabetes Association (ADA), se reconocen como factores de riesgo de desarrollo de DM2 las siguientes situaciones:\n- IMC > 25 kg/m² (23 kg/m² en asiáticos).\n- Familiar de primer grado con diabetes.\n---\n# DIABETES 2\n\n- Etnias de alto riesgo: afroamericanos, latinos, americanos de origen asiático, islas del Pacífico).\n- Historia previa de enfermedad cardiovascular.\n- Hipertensión arterial.\n- Dislipidemia.\n- Sedentarismo.\n- Historia previa de diabetes gestacional.\n- Mujeres con síndrome de ovario poliquístico.\n- HbA1c > 5,4%.\n\nReferencias:\n- American Diabetes Association. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S29-S33.\n\n## COMENTARIO\n\nEl manejo del estilo de vida es un aspecto fundamental de la atención de la diabetes e incluye el DSME (Educación y Apoyo para el Autocontrol de la Diabetes), la terapia de nutrición médica, la actividad física, el asesoramiento para dejar de fumar y la atención psicosocial.\n\nLa metformina es el agente farmacológico inicial preferido para el tratamiento de la DM2. Una vez iniciado, la metformina debe continuarse mientras sea tolerada y no esté contraindicada; otros agentes, incluida la insulina, deben agregarse a la metformina.\n\n### Tabla 1. Criterios diagnósticos de diabetes según la American Diabetes Association\n\n| Criterios diagnósticos de diabetes |\n|-----------------------------------|\n| GPA ≥ 126 mg/dl (7,0 mmol/l). El ayuno se define como la ingesta de calorías durante al menos 8 h* |\n| o |\n| 2-h GP ≥ 200 mg/dl (11,1 mmol/l) durante TTOG. La prueba debe realizarse como lo describe la OMS, utilizando una carga de glucosa que contenga el equivalente de 75 g de glucosa anhidra disuelta en agua* |\n| o |\n| A1C ≥ 6,5% (48 mmol/mol). La prueba se debe realizar en un laboratorio, utilizando un método que esté certificado por NGSP y estandarizado al ensayo DCCT* |\n| o |\n| En un paciente con síntomas clásicos de hiperglucemia o crisis hiperglucémica, una glucosa plasmática aleatoria ≥ 200 mg/dl (11,1 mmol/l) |\n\nGPA: glucemia plasmática en ayunas; GP: glucosa plasmática; TTOG: test de tolerancia oral a la glucosa. NGSP: National Glycohemoglobin Standardization Program; DCCT: Diabetes Control and Complications Trial).\n\n*Para las tres pruebas, el riesgo es continuo, se extiende por debajo del límite inferior del rango y se vuelve desproporcionadamente mayor en el extremo superior del rango. En ausencia de una hiperglucemia inequívoca, el diagnóstico requiere dos resultados de prueba anormales de la misma muestra o en dos pruebas de muestras separadas.\n\nAdaptado de: American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl. 1):S13-S28.\n\nReferencias:\n- American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13-28. doi: 10.2337/dc19-S002. Review. PubMed PMID: 30559228.\n- American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S90-102. doi: 10.2337/dc19-S009. Review. PubMed PMID: 30559235.\n\n## 7. Los criterios de definición de prediabetes o categoría de riesgo aumentado para DM2 según la American Diabetes Association son:\n\nA. Glucemia basal entre 100 y 125 mg/dl.\nB. Glucemia a los 120 min tras sobrecarga oral de glucosa entre 140 y 199 mg/dl.\nC. HbA1c entre 5,7 y 6,4%.\nD. Todas son ciertas.\n\n### COMENTARIO\n\nLas tres categorías indicadas definen situaciones de prediabetes según la American Diabetes Association.\n\nReferencias:\n- American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl. 1):S13-S28.\n\n## 8. Varón de 50 años, asintomático, que presenta en dos análisis de empresa gluc\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}